24/7 QualityMeds Blog – Access to Medicines & Healthcare Updates in India

Braftovi is a prescription medicine given to adults suffering from cancer, whose cells have a mutation (change) in their genes known as BRAF V600. Encorafenib is the key ingredient present in Braftovi and patients looking to buy encorafenib in India can access it through a regulated Named Patient Program. It facilitates by obstructing the BRAF protein, thereby terminating the activation of cell division, eventually reducing the growth and spread of cancer. Indications Braftovi is indicated in patients who require access to Encorafenib in India through a Named Patient Program. 1) Melanoma Braftovi is taken in combination with binimetinib for the treatment of unresected or metastatic melanoma with BRAF V600E mutation, as detected by an FDA-approved test, and eligible patients may import encorafenib in India under the Named Patient Program. 2) Colorectal Cancer In combination with cetuximab and mFOLFOX6, for the treatment of patients with metastatic Colorectal Cancer (mCRC), as detected ...

What is Abatacept? Abatacept is a soluble fusion protein produced by recombinant DNA technology, with the extracellular domain of human cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) linked to the modified Fc portion of human immunoglobulin G1. Patients looking to buy Abatacept in India usually access it through regulated import programs. It inhibits T cell activation by binding to CD80 and CD86, and thus blocking interaction with CD28. This interaction provides a costimulatory signal necessary for full T cell activation. Activated T lymphocytes are implicated in the pathogenesis of rheumatoid arthritis and are found in the synovium of patients with RA. Who is it for? Abatacept is indicated fpr reducing signs and symptoms By inhibiting progression of structural damage and improving physical function in adult patients with moderately to severely active rheumatoid arthritis. Abatacept can be used as a monotherapy or concomitantly with disease modifying antirheumatic drugs besides ...